[热闻寻踪] 三生制药辉瑞强强联手 资本热潮下国内药企在研新药大揭秘!附件:

全景网
21 May

传闻纷飞,严谨求证,掌握权威、真实的声音。近日,三生国健一份与辉瑞公司的合作项目公告,提升了市场对国内创新药的前景展望,并引发资本市场强烈反响,生物科技板块多只个股异动,其中三生国健收获三连板,舒泰神20cm涨停,赛升药业大涨16%。5月20日,三生制药宣布该公司及附属子公司沈阳三生、三生国健与辉瑞(Pfizer)签署协议,将向辉瑞独家授予PD-1/VEGF双特异性抗体SSGJ-707在全球(不...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10